Cite

    Francesco Zaja et al.. “Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice.” American journal of hematology, vol. 88, no. 11, n.d., pp. 955–960. http://access.bl.uk/ark:/81055/vdc_100024726477.0x00000e